Abstract A unified approach to affinity screening for Fab and Fc interactions of an antibody for its antigen and FcγR receptor has been developed. An antigen array is used for the Fab affinity and cross-reactivity screening and protein A/G proxy is the FcγR receptor. The affinities are derived using a simple 1:1 binding model with a consistent error analysis. The association and dissociation kinetics are measured over optimised times for accurate determination. The Fab/Fc affinities are derived for ten antibodies: mAb-actin (mouse), pAb-BSA (sheep), pAb-collagen V (rabbit), pAb-CRP (goat), mAb-F1 (mouse), mAbs (mouse) 7.3, 12.3, 29.3, 36.3 and 46.3 raised against LcrV in Yersinia pestis. The rate of the dissociation of antigen-antibody complexes relates directly to their immunological function as does the Fc-FcγR complex and a new half-life plot has been defined with a Fab/Fc halflife range of 17-470 min. The upper half-life value points to surface avidity. Two antibodies that are protective as an immunotherapy define a Fab half-life >250 min and an Fc halflife >50 min as characteristics of ideal interactions which can form the basis of an antibody screen for immunotherapy.
Introduction
Characterisation of the affinity of antibodies for its target species is important in many medical applications including passive immunity from anti-sera, humanised antibodies for immunotherapy [1, 2] and chemotherapy [3, 4] and in assessing the immune response of an animal for vaccine candidate screening [5, 6] . An antibody's affinity for its target antigen is controlled by interactions at the Fab binding site [5, 7] and, ideally, should not have any cross-reactivity with accidental epitopes within the blood or tissue proteome of the patient. The two identical Fab binding sites allow for an enhanced interaction from both simultaneous interactions in multivalent binding, termed avidity; two binding sites for different epitopes is termed bispecific [8] .
By contrast to the Fab region, the Fc region is rarely profiled, but the Fc binding affinity for the FcγR receptors on the surface of phagocytes is essential for mounting an effective immune response [9, 10] . A potential proxy for the FcγR is the affinity with bacteria evasion proteins, protein A, protein G and the hybrid protein A/G [11, 12] . These proteins have evolved in a selection of bacteria as evasion mechanisms, binding human IgG at the Fc region to prevent interaction with the C1q proteins of the complement cascade and the clearance of antibody-antigen complexes. Structural comparisons for protein A, protein G [12, 11, 13] and FcγR binding to IgG involve similar antibody residues on the Fc region and are therefore expected to be important in both complexes; hence, the affinity for the evasion protein has potential to be a good proxy for the FcγR protein interactions. Combining the Fab affinity screen for target antigens and potential crossreactivities with the Fc affinity for the FcγR proxy can provide an affinity screen for all potential humanised antibody therapies or vaccine candidates.
A label-free localised particle plasmon antibody screening array [12, 14] ), rate constants and hence the binding affinity constant, K D =k d / k a (M). Plasmon resonance has been used in a large number of studies to determine the affinity constants for protein-protein interactions using different fitting procedures, most however, assume a 1:1 binding or Langmurian model. The accuracy of the 1:1 model and its implementation on different platforms have been assessed globally with significant variability [15, 16] . The implementation of a reproducible analysis quantitatively and the accuracy of the derived constants is essential for comparison studies and characterisation of therapeutic antibodies. Central to the optimised protocol is the formation of reproducible protein surfaces with known, controlled concentrations of binding epitopes and the subsequent analysis of the data so that the goodness-of-fit of the binding model can then be scrutinised. Only then can affinity constants be compared.
The aim of the current study is to provide a robust protocol for the assessment of errors in the analysis of the 1:1 binding model and identify the experimental requirements and analysis to establish confidence and accuracy in the measurements. We have printed an array for screening the Fab affinity against the target antigens to assess potential cross-reactivity to other epitopes and screen the Fc affinity using the protein A/G binding affinity FcγR proxy. The data are interpreted using the 1:1 binding model with a statistical analysis fitted over a range of concentrations simultaneously. The necessary association and dissociation phase measurement times for our experimental conditions will be determined and a χ 2 -optimised data fitting procedure with local and global noise assessment will be developed and compared. A global fit analysis protocol with known error propagation will then be derived. The global fit analysis will be performed for polyclonal and monoclonal antibodies raised in a number of different host species; however, the measured parameters need to be calibrated against known immune-protective antibodies. mAbs were profiled with known protective properties in antibodies derived from vaccination and are used to calibrate the affinity parameter space.
Experimental methods and materials Materials
Materials were used as purchased and without further purification.
The following were purchased from Sigma Aldrich: N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS), bovine serum albumin (BSA, 98 %), C-reactive protein (CRP) and human fibrinogen (60 with 40 % buffer salts; the protein content is >80 % clottable fibrinogen), anhydrous N,N-dimethylformamide (DMF) and Lomant's reagent dithiobis-succinimidyl propionate (DSP). Standard phosphate buffered saline (PBS) purchased from Sigma-Aldrich in tablet form unless otherwise stated. For all binding studies, but not for surface preparation, 5×10 −5 Tween 20 (w/v) was added to the prepared PBS buffer.
Recombinant protein A/G was supplied from Pierce. The SAM components used were HS-(CH 2 )17-(OC 2 H 4 )3-OH (used as a 'spacer ') and HS-(CH 2 )17-(OC 2 H 4 )6-OCH 2 COOH (used as a 'linker'), both were obtained from ProChimia Surfaces. Purified proteins purchased from Abcam included Actin, and Collagen Type V. F1 protein was supplied by DSTL, Porton Down. Recombinant LcrV protein (200 mg/mL) of Yersinia pestis (strain GB) was produced as previously described [17] . All mAbs used were raised in Balb/c mice against LcrV, and details of the antibody production are available elsewhere [18] . All of the mAbs were characterised as IgG1 isotype. Mab7.3 was produced from the splenocytes of mice immunised with SDS-treated LcrV. Details of the antibodies used are summarised in Table 1 .
Methods
The antibody screening arrays were designed using our inhouse procedure and array reader measurement platform that has been reported in detailed elsewhere [14] and will be presented here briefly. The localised plasmon array is printed into a 12×8 configuration by an inkjet printer (Arrayjet Aj100) from a seed solution of gold nanoparticles with mean diameter of 4 nm [19] [20] [21] [22] . The array spot elements are 200 μm in diameter and 300 μm apart. The seed-printed array is removed from the printer and placed in a development solution to allow surface synthesis of the sensor surface nanoparticles. The resulting particles are typically 90 nm in diameter and have a surface coverage within each array element of approximately 10 % [20, 23] . The nanoparticles are then functionalised in solution with a self-assembled monolayer (SAM) containing thiol group on one end for thiol-coupling to the Au surface and another end has either a linker (carboxyl group) for protein coupling or a spacer (alcohol group) in the ratio 1:10. The resulting SAM provides binding sites for peptide coupling and a hydrophobic surface to minimise non-specific binding. The array is activated with EDC/NHS and returned to the printer where target proteins are printed onto the array at a concentration of 2 mg/mL in the required array assay configuration. Fibrinogen (Fbr) and bovine serum albumin (BSA) are printed as control spots to allow for local changes in analyte solution refractive index, temperature and illumination intensity of the light source. The array is installed into the array reader where it is illuminated by a 660-nm LED (Thorlabs, 100 mW) in a total internal reflection configuration on a Dove prism. Scattered radiation from the plasmon array spots is recorded normal to the surface of the Dove prism by a video camera capturing 15 frames per second. The data from 16 arrays spots are averaged together to produce the assay for the protein A/G or the target antigen proteins. Each array is blocked with HSA (100 μM) for 10 min to reduce non-specific binding, and the antibodies are passed over the array to record the association and dissociation phases. The period of measurement of each phase depends on the magnitude of the rate constants to be determined. Fitting the kinetic traces of a number of assays with different antibody concentrations was performed simultaneously-a global fit.
Results and discussion
The Fab and Fc affinity was determined for all of the antibodies by measuring the binding kinetics at 5 concentrations starting at 10 nM antibody solution followed by a series of dilutions. The assays are formed with eight concurrent repetitions on a 96-well array of gold nanoparticle elements. The active sensor surface is a set of nanoparticles with average radius 120 nm, and the assay kinetics is monitored in real time following the light scattered from each array element. Fbr is used as the reference channel and subtracted from the data to correct for changes in temperature, refractive index of the medium and the intensity field of the illuminating LED [24] [25] [26] 14] . Examples for pAb (BSA)-BSA and pAb (CRP)-protein A/G are shown in Figs. 1 and 2 , respectively. The data show a characterised association phase followed by a switch to PBS to the dissociation phase. The exact time for determining accurately each phase depends on many factors, including the surface protein density, the signal sample frequency, the signal-to-noise ratio and the magnitude of the kinetic parameters.
The standard model for the interpretation of association and dissociation kinetics at sensor surfaces is a simple 1:1 binding model with the target analyte binding to one of a number of identical/equivalent sites on the surface, filling without any interaction between adjacent sites [16] . The integrated kinetic equation is given by (1) for the association phase and (2) for the dissociation phase:
where ϑ(t) (RIU) is the variation of sensor response with time, ϑ m (RIU) is the response at the maximum surface coverage, ϑ a (RIU) is the sensor response at the end of the association phase,
) is the association rate constant, [P] is the analyte protein concentration and
) is the dissociation rate constant. The relative surface coverage is always given as ϑ(t)/ϑ m ratio. The equations can be fitted to the data for each concentration k a and k d rate constants with independent ϑ m parameter for each concentration [P] . Additional parameters in the fit include the start points of the association phase in each case and the start point of the dissociation phase. The early stage of the association phase is dominated by the passage of the solvent front which has a transit time of typically less than 60 s. The front kinetics can be included in the kinetics explicitly [16] or removed from the fit making the start point for the association phase after the passage of the solvent front. Similarly, non-specific binding may be present on the sensor surface at the beginning of the dissociation phase and a start point may also be fitted to remove eliminate this effect.
The 1:1 model can break down in many ways [15] , and it is important to know when breakdown occurs. Cooperative association kinetics allows interaction between proteins already present on the surface with those arriving increasing or decreasing the association rate constant: low protein surface densities are a possible mitigation. Interfacial diffusion to the surface: These terms may be excluded explicitly in the kinetics analysis along with a full fluid dynamic description although the increased complexity of the model may not yield to a better determination of the fitting parameters which may be highly correlated. The early phases of the association and dissociation may be linear to a good approximation (Taylor series expansion of the exponential functions) which may be adequate to determine the association and dissociation parameters but the simple model is clearly and assumption. The dissociation kinetics are best observed over an extended period related to the half-life of the complex and with a good signal-to-noise ratio favouring higher surface concentrations conflicting with the low surface coverage required to eliminate cooperative binding effects. The aim of the fitting process is the reliable determination of the kinetic parameters to describe the protein-protein interactions reproducibly to allow for comparative analyses in screening applications. The fit however needs a measure of goodness-of-fit that is, however, difficult to define. The obvious choice is χ 2 ; the absolute value of which and the numbers of degrees of freedom would define a distribution on which a hypothesis tests could be performed. However, for non-linear models, the number of degrees of freedom is not well defined formally [27] . In practice, all fits to the simple 1:1 model would typically fail a hypothesis test based on the χ 2 with any estimate of degrees of freedom. The usual approach is to adopt a rule of thumb for the value of χ 2 , of say 100, an approach that has been termed BChi-by-eye^ [28] , but this must depend on the signal sampling frequency and the lowand high-frequency noise distributions of each instrument and suggests an arbitrary cutoff limit which needs to be consistent between platforms.
The proposed solution is a simultaneous fit to a number concentrations of analyte allowing for early-time estimates of the association and good signal to noise for the dissociation phase but also experimental evidence or otherwise of cooperative effective at the surface. The 1:1 model can be fitted to all traces simultaneously minimising the residuals weighted by the noise which allows χ 2 do be defined as:
where (x i −t i ) is the residual or difference between the observed value x i and the theoretical value, t i . The noise in the analysis is defined by σ i either estimated at each data point, local noise or estimated from the beginning or end of each (1) and (2) using global noise; B the residuals spectrum for the fit plotted against time; C the histogram of the residuals with mean±SD 3±29 μRIU and an ideal normal distribution. The concentrations studied from top to bottom followed a twofold dilution from 10 nM trace, global noise. The local noise is determined from selecting 16 s data either side of the central point with the signal fitted to a quadratic function that is then subtracted from the data to produce a noise spectrum from which the local standard deviation σ i is derived and used as weight for each residual in the fitting process. The global noise spectrum is derived from 100 points at the beginning of the kinetic trace prior to injection of the sample and used as a constant weight of in χ 2 at each analyte concentration. The fitting process produces a line of best fit, a value for χ 2 , residuals spectrum as a function of time throughout the global fit and a residuals histogram. The fit data are shown in Fig. 1 for aBSA binding to BSA and aCRP binding to protein A/G (Fig. 2) . The fitting coefficients for each data set and the correlation matrix between them are shown in Table 2 with the derived parameters and quality-of-fit metrics for the antibody set shown in Table 3 .
The residual spectrum is a potentially more useful measure of goodness-of-fit as can be seen in Fig. 1b Fig. 2b , c shows significant deviations in the residuals during the association and dissociation phase, although the model fits better to the first-order dissociation kinetics. The effect of local and global noise can be assessed using the residuals, as summarised in Fig. 3 . There is no significant difference between the point-specific local noise or the global noise weighting to χ 2 as judged by the absolute value of χ 2 , the mean of the residuals, standard deviation of the residuals and the value of R 2 . The value of the mean of the residuals is close to zero within one standard deviation of the distribution. However, the residuals distribution always fail the hypothesis test for normality with P values less than 10 −9 (KolmogorovSmirnov test) ( Table 3 ). The residual distribution points towards breakdown of the model in Eq. (1) during the association phase and Eq. (2) during dissociation. The association of the antibodies to their epitopes on the surface is generally well described by the 1:1 binding model, although may breakdown with the onset of multi-site binding avidity. However, the Fc 1:1 binding to protein A/G is less well determined as expected: Each protein A/G contains multiple binding sites [29] for the antibody and should demonstrate cooperative binding. The absolute value of χ 2 , the mean of the residuals or the normality of the residuals all point to the intrinsic inaccuracy of the 1:1 binding model.
The quality-of-fit measures based on the spectrum of residuals, χ 2 absolute value (rule of thumb) and R 2 can be used to optimise the measurement times for the association and dissociation phases specific to the instrument and the signal-tonoise ratio. The objective of the analysis is to determine the kinetics of the protein-protein interactions with consistent accuracy, target of 5 %, to allow comparative analysis and screening. The different kinetic phases provide information about the interaction: The association phase of the fit is a function of both k a and k d , the concentration of the protein, [P] i , and the maximum coverage response, ϑ m i, whereas the much slower dissociation phase is determined by k d alone. The k a association rate constant and θ m maximum coverage response are both well determined only in the association phase; at higher concentrations, the off-rate characterised by θ(t)×k d begins to contribute and can be determined accurately (Fig. 3) . Since the overall rate constant of deposition is described by (k a [P]+k d ), the trace with largest analyte concentration [P] is most sensitive to the value of k a . For [P]=32 nM, it takes about 210 s to define k a with less than 5 % error that translates into 58 % of the maximum coverage or 70 % of the equilibrium coverage reached (Fig. 3a) . The global fit to a range of concentrations for both association and dissociation rates contains different levels of parameter correlations as can be seen from the correlation coefficients in Table 2 .
A series of the simulations was performed to determine how the analyte concentration, number of the kinetic traces in the dataset and noise present in the signal affect the accuracy of the k a and k d rate constants derived from the fit of the simulated data within 1:1 kinetic model. The results are shown in Fig. 3 . Panel A shows that a single kinetic trace with the largest analyte concentration, 32 nM, yields k a with the same accuracy as a set of three traces, 2-8-32 nM if the ϑ m i are allowed to vary independently for each trace. However, the global fit to ϑ m produces a lower error fit reaching the target accuracy in half the measurement time of the association phase. The potential for better accuracy errors associated with longer association phase measurements can also be quantified. Similarly, the accurate determination of k d in the dissociation phase depends on the length of time for which dissociation is recorded (Fig. 3b) . The dissociation phase is a simple firstorder decay, and a 5 % precision level requires typically a change of 3× signal-to-noise ratio or 160 s in the array reader Table 2 Correlation coefficients derived from the global fit for aCRP binding to protein A/G data presented in Fig. 2 instrument. The length of measurement of the dissociation phase is given by:
where σ describes signal-to-noise ratio and is derived from the beginning of the trace (global noise). Typically, the error in k d reaches 5 % error after 10-20 min (Fig. 3b) . Again, higher accuracy may be achieved with longer measurements and the improvement may be quantified.
The global fit protocol over a range of analyte concentrations with fixed surface concentration allows the 5 % accuracy limit to be achieved, defining the consistent measurement lengths for the association and dissociation phases. The residual spectrum provides a clear indication of the breakdown of the 1:1 model as can be seen in Fig. 2b affecting the error, suggesting breaches of the 5 % accuracy limit are indicative of cooperative binding or avidity. The comparison between samples is then possible with quantified comparable errors; the fit technicalities are not introducing any additional errors associated with highly correlated parameters.
The binding affinities derived for the antibody set in this study are shown in Table 3 (Table 4) . A half-life plot may be constructed, plotting the τ(Fab) vs τ(Fc) to summarise the properties of the antibodies (Fig. 4) . The mAb7.3 and mAb 29.3 have shown to be protective as a therapy in mice for Y. pestis [30, 31] and indicate a region of the τ-τ plot that might be used to screen the efficacy of an antibody before testing in an animal model.
The errors in the affinity constants such as for mAb 7.3 and the larger errors in the protein A/G assays point to non-1:1 binding activity either as cooperative binding or surface avidity. Protein A/G has six antibody binding sites on each protein and would be expected to show cooperative binding consistent with the residuals spectrum in Fig. 2b which is more pronounced at higher antibody concentrations. Interestingly, the affinity constant determined for the LcrV antibody mAb 7.3 has an error of 11.1 % indicative and has the longest halflife indicative of surface avidity. The LcrV protein is part of the injectisome of and is a long filamentous protein which would allow both Fab regions to bind to the protein, demonstrating avidity. The accuracy of the affinity constants derived using the current method is critical comparisons that are to be drawn. There are a number of factors that must be considered [16] to ensure there are sufficient data points to sample the lifetime characteristics accurately and to be clear when the 1:1 model breaks down. A single figure of merit such as χ 2 is not sufficient, and only the error plots shown in Fig. 3 provide confidence in the accuracy at a chosen level. Multiplexed platforms have additional problems associated with spot-to-spot variation [32, 24] in sensitivity, printed protein concentration and sample depletion where spots upstream in the flow change the concentration of reagents landing on downstream spots. Sample depletion requires mass transport effects to be considered and investigated using non-1:1 model [33] mass transport model. There is no evidence of the breakdown of the 1:1 model given the flow characteristics of our instrument and the number of array spots.
Conclusions
We have demonstrated that the nanoparticle array format sensor platform performs consistently with controlled errors to match the performance of the single, large surface plasmon platforms [33] . The consistent error in the determination of kinetic parameters points to global fit analysis for the comparison of binding attributes demonstrated here for several different clones to the same protein and has established a measurement requirements that are essential for all platforms [16, 33] . More complex binding models, non-1:1, leading to cooperative binding and avidity measurements, can be confidently identified and summarised in a half-life plot. Off-rate screening [34] has been proposed as a method for assessing the potential of ligands with targets and can be adapted here. A plot of τ 1/2 (Fab) vs τ 1/2 (Fc) provides a localisation of the performance of the antibody and two new measures of its potential for characterising immuno-protection rather than affinity profiling [35] . The half-life plot (Fig. 4) , when populated with a number of protective antibodies and linked to an epitope mapping study [30] , is a powerful in vitro screen of candidate vaccines or immunotherapy drugs prior to testing in an animal model. However, the comparisons between SPR platforms would require international sample standards which are a compelling proposition.
